VIDASAFE-MET 50/1000 TABLET

Product Description

VIDASAFE-MET 50/1000 TABLET | Vildagliptin 50mg + Metformin 1000mg

Optimize diabetes management with VIDASAFE-MET 50/1000 Tablet, a clinically formulated combination of Vildagliptin and Metformin designed for effective glycemic control in Type 2 diabetes patients. This powerful antidiabetic tablet leverages the complementary mechanisms of action of Vildagliptin (a DPP-4 inhibitor) and Metformin (a biguanide) to regulate blood glucose levels efficiently.

Key Benefits:

• Enhances insulin secretion and improves pancreatic beta-cell function

• Reduces hepatic glucose production and increases peripheral glucose uptake

• Provides sustained blood sugar control with reduced risk of hypoglycemia

• Supports weight neutrality and improves insulin sensitivity

• Convenient fixed-dose formulation for better patient compliance

Usage:
Indicated for adult patients with Type 2 diabetes mellitus, VIDASAFE-MET 50/1000 is prescribed to be taken orally as part of a comprehensive diabetes management plan including diet and exercise. Ideal for patients inadequately controlled on monotherapy or requiring combination therapy for optimal glucose regulation.

Why Choose VIDASAFE-MET 50/1000?

• Manufactured under stringent quality standards ensuring efficacy and safety

• Suitable for bulk procurement by medical distributors and pharmaceutical retailers

• Competitive pricing and reliable supply chain support for large-scale distribution

• Perfect fit for hospitals, clinics, and pharmacies focusing on diabetes care